Gotham Asset Management »

Travere Therapeutics shares owned by Gotham Asset Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Gotham Asset Management from 13F filings

Historical chart of Gotham Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Gotham Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $843k 28k 29.71
2025-12-31 $2.1M 56k 38.21
2025-09-30 $663k 28k 23.90

More positions owned by Gotham Asset Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Tidal Trust I Gotham Enhncd (GSPY)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Snowflake Com Shs (SNOW)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Ishares Tr Russell 3000 Etf (IWV)
Broadcom (AVGO)

View all positions for Gotham Asset Management

Top funds holding Travere Therapeutics

Henderson Group
FMR
BlackRock
Vanguard Group
Armistice Capital
State Street Corporation
Perceptive Advisors
Vanguard Capital Management
Nomura Asset Management International
Adage Capital Partners GP
Kynam Capital Management
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Goldman Sachs Group

View all funds holding Travere Therapeutics